Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$204K Buy
+945
New +$181K 0.02% 670
2024
Q4
Sell
-2,424
Closed -$470K 530
2024
Q3
$470K Buy
2,424
+1,397
+136% +$292K 0.06% 328
2024
Q2
$238K Sell
1,027
-413
-29% -$89.8K 0.05% 357
2024
Q1
$311K Buy
1,440
+290
+25% +$67.9K 0.06% 320
2023
Q4
$298K Sell
1,150
-996
-46% -$245K 0.05% 202
2023
Q3
$552K Buy
+2,146
New +$574K 0.18% 122

Other funds holding BIIB

Norden Group's BIIB Position: Q2 2026 in Review

Norden Group opened a new position in Biogen (BIIB) in Q2 2026: 945 shares worth $204K. The stake represents 0.02% of the portfolio and ranks #670 among its holdings. This is a return to the name: Norden Group previously reported a position in BIIB as recently as Q3 2024.

Norden Group first reported a position in BIIB in Q3 2023 and has held it in 6 quarters since. The position peaked at $552K in Q3 2023. 1,042 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Norden Group held 945 shares of Biogen worth $204K as of Q2 2026.
  • Biogen was a new Norden Group position in Q2 2026.
  • Biogen made up 0.02% of Norden Group's portfolio in Q2 2026, its #670 holding.
  • Norden Group first reported a position in Biogen in Q3 2023 and has held it in 6 quarters since.
  • Norden Group's Biogen position peaked at $552K in Q3 2023.
  • 1,042 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Norden Group's 13F filing for Q2 2026, filed 29 Jul 2026.